This year's annual observation of National Infant Immunization Week is April 27-May 4, 2019. NIIW highlights the importance of protecting infants from vaccine-preventable diseases and to celebrate the achievements of immunization programs and their partners in promoting healthy communities. This is the 25th anniversary of NIIW. Since 1994, hundreds of communities across the United States
Save the Date: Team Aberdeen Proving Ground (APG) anticipates hosting the APG Discovery Week Advanced Planning Briefing to Industry (APBI) the week of 29 April-3 May 2019, at APG, Maryland. APG is home to more than 70 tenant organizations, including: Joint Program Executive Office for Chemical Biological Defense (JPEO-CBD) US Army Research Lab (ARL) US
CDC’s 68th annual Epidemic Intelligence Service conference starts April 29. Join CDC disease detectives, alumni, and the public health community to learn about leading-edge public health investigations. The annual EIS conference is the nation’s premier epidemiology conference where EIS officers share their work in leading-edge investigations, scientific findings, and forward-thinking strategies to inform improvements in
The Cedars-Sinai Special Pathogens Symposium 2019 will be held 29 April 2019 in Los Angeles, CA. Hospital preparedness stakeholders from within the region will gather to foster institutional collaboration and education on frontline, assessment and treatment of high-consequence infectious diseases. Highlighted topics include: Global events related to low-incidence, high-consequence infectious pathogens Research and methods to
Entries are being accepted for the Eureka Prize for Infectious Diseases Research through 3 May 2019. Activity entered for this prize must have been undertaken in Australia or its territories (as defined by the Australian Government). For a team entry, the team leader must be either a) an Australian citizen, b) an Australian permanent resident,
The Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office is holding a Proposers Day meeting on 17 May 2019 to provide information to potential proposers on the objectives of the new ReVector program and to facilitate teaming. The goal of ReVector is to develop an easily delivered treatment — for example, a topical solution
The U.S. Army Medical Research Acquisition Activity (USAMRAA) located at FT. Detrick, MD, has issued a solicitation outlining plans to conduct User Acceptance Testing for the malaria prophylactic drug (Tafenoquine) brand name Arakoda. The operational testing will look at the drug’s performance attributes and usability. The DoD is seeking sources, capability statements, and industry feedback
